Gustav III of Sweden's coffee experiment
Gustav III of Sweden's coffee experiment was a scientific study conducted in the 18th century by King Gustav III of Sweden to investigate the health effects of coffee consumption. This experiment is often cited as one of the earliest examples of a controlled trial in medical history.
Background[edit]
During the 18th century, coffee was a controversial beverage in Sweden. Many believed it to be harmful, and it was associated with various health risks. King Gustav III, who reigned from 1771 to 1792, was interested in the potential health effects of coffee and sought to prove that it was harmful.
The Experiment[edit]
The experiment involved two identical twin brothers who had been sentenced to death for crimes. Gustav III commuted their sentences to life imprisonment on the condition that one twin would drink three pots of coffee every day for the rest of his life, while the other twin would drink an equal amount of tea. The experiment was designed to observe the long-term effects of coffee consumption compared to tea.
Methodology[edit]
The twins were monitored by a team of physicians, and the experiment was intended to continue until one of the twins died, thereby providing evidence of the relative safety or danger of coffee. The physicians were tasked with regularly examining the twins and reporting on their health.
Outcome[edit]
The results of the experiment were inconclusive. The twin who drank tea died first, at the age of 83, while the coffee-drinking twin outlived him. However, both King Gustav III and the overseeing physicians died before the experiment concluded, leaving the results largely unrecorded and the experiment unfinished.
Significance[edit]
Gustav III's coffee experiment is significant as an early example of a controlled trial, despite its methodological flaws and lack of scientific rigor by modern standards. It reflects the historical context of medical experimentation and the evolving understanding of nutrition and health.
Legacy[edit]
The experiment is often referenced in discussions about the history of coffee and its cultural impact in Sweden. It highlights the historical skepticism towards coffee and the lengths to which authorities went to understand its effects.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian